LabCompass

Nicholas Marschalk

Medicine · The Ohio State University

OpenAlex ORCID
Mid career · publishing since 2008
Antifungal resistance and susceptibilityTransplantation: Methods and OutcomesCystic Fibrosis Research AdvancesFungal Infections and StudiesSimulation-Based Education in Healthcare

Publications

12

Citations

16

Est. group size

—

Recurring co-author estimate

Active years

19

Publishing since 2008

Research summary
AI-generated

Nicholas Marschalk's work focuses on infections in patients who have received organ transplants, including fungal infections (such as Aspergillus and mucormycosis), viral infections (like Kaposi Sarcoma-associated herpesvirus and RSV), and device-related bacterial infections. The research also includes studies on antibiotic management strategies for transplant patients and the development of simulation-based tools for training doctors in transplant infectious disease decision-making.

Transplant infectious diseaseFungal infections (antifungal resistance)Viral infections in immunocompromised patientsAntibiotic management strategiesMedical education and simulation training

Publication output has grown modestly over the last decade, rising from sporadic single papers before 2021 to a steadier pace of 1-3 publications per year since 2022.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.8/year recently
172018: 1 publication1819202021: 1 publication212022: 2 publications222023: 3 publications3232024: 1 publication242025: 1 publication252026: 2 publications26
Recent publications
Publishes in
  • Open Forum Infectious Diseases×6
  • Transplant Infectious Disease×2
  • MMWR Morbidity and Mortality Weekly Report×1
  • BMC Infectious Diseases×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile